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INTRODUCTION 
 
 Dairy producers and those who advise them are well aware of the challenges that 
face cows during the transition to lactation. The 2-3 week period after calving typically 
accounts for 25 – 50% of health problems on a dairy, and high cull rates in early lactation 
are a costly problem for many farms. Research conducted over the past 2 decades has 
revealed strong evidence that part of the problem during this time is suppression of the 
immune system during the transition period. Both innate immunity (responsible for quick, 
general responses to pathogens) and acquired immunity (dependent on immune 
“memory”) are impaired during this period of time. This diminished immune function 
occurs at a time when nearly all cows experience some degree of inflammation, which is 
somewhat counter-intuitive given that inflammation is a critical tool for immune system 
activation. Furthermore, measures of immune function and inflammation are predictive of 
disease incidence in dairy cows, suggesting that changes to support immune function 
and to limit inflammation may improve the well-being and productivity of cows. 
 
IMMUNITY IN TRANSITION COWS 
 
During infections such as mastitis or metritis, immune cells in the body recognize 
invading pathogens and become activated. The non-specific, rapid response arm of the 
immune system is called innate immunity, and is triggered by general pathogen-
associated molecules, such as endotoxin. The pathogen-specific arm that provides a 
potent “memory” based targeted response is called adaptive immunity; this is the arm that 
is targeted by vaccination. Even though these aspects of immunity are often discussed 
separately, in reality these systems communicate constantly.  
 
The activation of local and systemic host defense mechanisms requires cross-talk 
between numerous types of immune cells, and one component of this response is 
inflammation. The host of signaling molecules released by activated immune cells 
includes inflammatory mediators such as nitric oxide, prostaglandins, and cytokines. 
Whereas many of these molecules promote local inflammation and increased blood flow 
to the infected tissue, inflammatory cytokines play a key role in stimulating systemic 
inflammatory responses, including increased body temperature, increased heart rate, and 
decreased feed intake. One effect of cytokines is to activate production of acute phase 
proteins. Primarily produced by the liver, proteins that participate in the acute phase 
response to infection are generally found in very low abundance in the bloodstream, but 
are greatly elevated during periods of systemic inflammation.  
 
 Why is the immune system of transition cows suppressed? The exact reasons for 
decrease immune function during the transition period are complex. However, studies 
with mastectomized cows made it clear that the primary driver is not gestation and calving, 
but rather lactation and the metabolic changes that come with it (Nonnecke et al., 2003). 
Numerous large studies have demonstrated that metabolic diseases (e.g. ketosis) put 
cows at higher risk of contracting clinical infections; likewise, cows with infectious 
diseases (e.g. metritis) are also at higher risk of subsequent metabolic disorders. The 
inter-dependent nature of the immune and metabolic systems in the animal are only now 
becoming clear, but high blood ketone and non-esterified fatty acid concentrations as well 
as hypocalcemia are known to limit the responsiveness of immune cells to pathogenic 
signals. Cows with excessive body condition experience more dramatic drops in immune 
function at calving, possibly as a consequence of oxidative stress. As a result, nutrition of 
the transition cow can have a large influence on immunity during this time, even beyond 
the vitamins and minerals that have received focus in the past. 
 
 Infections are obviously caused by a pathogen, but this new information suggests 
that the response of the cow to the pathogen should receive as much focus as the 
pathogen load when trouble-shooting disease problems on a farm. Data currently 
available suggests that cows have improved postpartum immune function when: 1) they 
are not exposed to significant heat stress during the dry period; 2) they calve with a BCS 
≤ 3.5; 3) they are supplemented with antioxidants during the dry period; 4) postpartum 
total serum calcium concentrations are maintained near 9 mg/dL, and 5) postpartum 
blood BHBA and NEFA concentrations stay below 1 mM. Considering the immune system 
of the transition cow does not necessarily require a change in recommendations for 
management during this period, but can provide additional motivation to prevent heat 
stress, provide sufficient access to feed, manage body condition, support calcium 
homeostasis, and monitor oxidative balance. 
 
INFLAMMATION DURING THE TRANSITION PERIOD  
AND ASSOCIATED OUTCOMES 
 
The presence of an acute phase response in postpartum dairy cows is well-
established (Bradford et al., 2015). Although early studies focused on associations 
between inflammatory markers and diseases such as mastitis and metritis, numerous 
studies in the past decade have demonstrated that inflammatory and acute-phase 
mediators are elevated in the days after parturition, even in cows that are apparently 
healthy. This growing body of evidence suggests that either the processes of parturition 
and galactopoiesis induce inflammation directly or that infections or endotoxin affect far 
more postpartum cows than is currently recognized. Whatever the explanation, the 
prevalence of postpartum inflammation raises important questions about the implications 
of this inflammation for early lactation cows. 
 
Although most transition dairy cows apparently experience a period of 
inflammation, the magnitude of this inflammatory condition varies greatly between cows. 
Bertoni et al. (2008) assessed the importance of this variation by measuring a panel of 
inflammatory markers and separating transition cows into quartiles for degree of 
inflammation. Cows in the highest quartile had significantly lower milk yields than those 
in the lowest quartile throughout the first month of lactation, differing by 20% on day 28 
of lactation (Bertoni et al., 2008). One metric that has been used in this respect is 
paraoxanase, a plasma biomarker that is potently suppressed by a variety of inflammatory 
stimuli. Transition cows with high paraoxanase concentrations, in addition to having lower 
concentrations of acute phase proteins and reactive oxygen metabolites, produced 4,346 
lb more milk (24%) over 305 days than those in the lowest quartile for paraoxanase 
(Bionaz et al., 2007). Other findings suggest that stronger inflammatory responses in the 
first week of lactation are associated with decreased whole-lactation milk yield (Huzzey 
et al., 2015). Plasma concentrations of haptoglobin (an acute phase protein) greater than 
1.1 g/L were associated with a 2,088 lb decrease in 305-day mature equivalent milk yield, 
and elevated haptoglobin was also associated with a 19% decreased risk of conception. 
Abnormally high markers of inflammation are associated with poor production, health, and 
fertility outcomes. 
 
One question that has not yet been addressed in observational studies is whether 
the pattern of inflammation impacts long-term outcomes. We hypothesize that brief spikes 
in inflammatory signals that are resolved in the first 3-4 days of lactation may aid in 
physiological adaptations to lactation and the end of pregnancy. However, failure to 
rapidly resolve these signals may lead to a variety of adverse impacts that ultimately 
impair productivity, health, and fertility (Figure 1). We hope that new data will begin to 
address this question in the coming few years. 
 
RESPONSES TO ADDED INFLAMMATORY STRESS 
 
 We recently reported on a study where we administered a very low dose of the 
inflammatory cytokine tumor necrosis factor α (TNFα) for the first 7 days of lactation to 
assess the impact of a subtle increase in postpartum inflammation (Yuan et al., 2013). 
Although our treatment did not induce any of the classical physiological signs of acute 
inflammation, we did observe significant increases in circulating mediators of 
inflammation, validating our approach to enhancing sub-acute inflammation. During the 
week of treatment, TNFα decreased feed intake by 18% and energy-corrected milk yield 
by 17%, with no change in energy balance. Furthermore, in the highest TNFα treatment 
group, 7 of 11 cows were diagnosed with at least one subclinical transition disorder, 
compared to just 2 of 11 in the control group. Along with a few other studies that have 
directly induced inflammation in the transition period (Trevisi et al., 2009), these findings 
demonstrate a causative role of inflammation in at least some common problems in early 
lactation. 
 
  
Figure 1. Hypothetical impacts of brief, rapidly resolved postpartum inflammation versus 
sustained inflammation. It is proposed that lack of resolution leads to impaired health and 
productivity rather than the inflammation per se. 
 
 
 
 
IMPACT OF POSTPARTUM ANTI-INFLAMMATORY TREATMENTS 
 
Milk Production Responses 
 
To address whether endogenous inflammation is also a problem, a variety of labs 
have used non-steroidal anti-inflammatory drugs (NSAID) to treat postpartum 
inflammation. In an preliminary study, Bertoni et al. (2004) treated 11 cows/treatment with 
lysine acetyl-salicylate (aspirin) or placebo for the first 5 days postpartum and monitored 
milk production through day 126 of lactation. Peak milk yield tended to increase with 
aspirin treatment (P < 0.10). The same group subsequently conducted a similar study 
with 23 cows/treatment and found that aspirin treatment over the first 5 days of lactation 
increased milk yield through day 60 of lactation (P < 0.05), with a 13% increase in peak 
milk yield (Trevisi and Bertoni, 2008). 
 
Motivated by these promising findings, we conducted a study with 78 cows 
assigned to either control or sodium salicylate delivered via drinking water (2 g/L) for the 
first 7 days of lactation. At first the results did not look very promising – salicylate 
decreased blood glucose and increased ketone concentrations in early lactation, with no 
increase in early milk yield (Farney et al., 2013a). However, as lactation progressed, the 
oldest cohort of cows treated with salicylate (those in parity 3 and greater) responded by 
producing 21% more milk over the full lactation, and fully 30% more milk fat, than parity-
matched controls (Farney et al., 2013b). On the other hand, primiparous cows treated 
with salicylate tended to produce less milk, suggesting a potential parity difference in 
either baseline inflammatory status or response to inflammatory signals. 
 
We subsequently completed a follow-up study to evaluate whether postpartum 
treatment of multiparous cows could increase whole-lactation productivity of cows on a 
commercial farm. To facilitate treatment in a commercial setting, we shortened 
postpartum treatment to 3 days (sodium salicylate) or 1 day (meloxicam) and compared 
them to placebo treatments (Carpenter et al., 2016) across 153 cows. Despite this very 
limited treatment window, cows treated with either NSAID produced 7 – 9% more milk 
over the whole lactation compared to placebo. Unfortunately, such treatments are not 
currently approved for commercial use. 
 
Several other groups in a variety of countries have failed to observe significant 
impacts of postpartum anti-inflammatory treatment on milk yield, and it remains to be seen 
whether a treatment paradigm can be found that is consistently effective. However, we 
believe that impacts on long-term milk yield likely require treatment early after calving 
(though not before the placenta is cleared); that treatment responsiveness is not limited 
to cows with calving difficulties; and that milk yield must be monitored for at least 60 days 
into lactation to have a good chance to observe the impact of anti-inflammatory treatment. 
 
Health Impacts 
 
Several NSAIDs have been used effectively in treating mastitis. In one study, 
carprofen had limited ability to suppress inflammation, but was shown to partially alleviate 
the decrease in ruminal contractions during induced mastitis in early-lactation cows 
(Vangroenweghe et al., 2005), which could help prevent a subsequent displaced 
abomasum. In another study, meloxicam treatment lowered somatic cell count and a 
reduced the number of cows removed (culled) from the herd after mastitis; most cows on 
the study were in early lactation (McDougall et al., 2009).  
 
A few studies have evaluated health impacts following blanket treatment with 
NSAID after parturition. In general, there has been little evidence of overall improvements 
in health or decreased risk of culling following early lactation NSAID treatment (Farney et 
al., 2013b, Meier et al., 2014). In fact, one small study suggested possible increased risk 
of infections after NSAID treatment (Bertoni et al., 2004). However, our commercial farm 
study that generated some intriguing results (Carpenter et al., 2016). Over the 365 days 
following treatment, meloxicam tended to delay removal from the herd based on survival 
analysis (P = 0.06; 30, 35, and 38 remained at 365 d postpartum for control, salicylate, 
and meloxicam, respectively). Meloxicam primarily affected early-lactation culling, and 
health records recorded by the farm suggested that metabolic disorders accounted for 
most of this decrease. More research is necessary to determine whether blanket 
treatment of postpartum cows can really decrease culling risk. 
 
 
 
Reproductive Responses 
 
The links between inflammation, reproductive tract infections, and infertility have 
motivated numerous groups to evaluate impacts of anti-inflammatory treatments on 
reproductive outcomes. Five studies that have utilized NSAID treatments in the first 2 
weeks postpartum and reported reproductive outcomes have been published, adding up 
to over 1,500 cows. Overall, these studies have shown little promise for decreasing the 
time to pregnancy after calving. However, Amiridis et al. (2001) found that adding flunixin 
meglumine to the antibiotic regimen used for treatment of puerperal metritis resulted in 
more rapid uterine involution and return to estrus. The unique benefit in this study 
suggests, not surprisingly, that NSAID treatment may have a greater impact on cows with 
an abnormal degree of uterine inflammation. Readers should note that many other studies 
have investigated various NSAID treatments near the time of breeding, outside of the 
transition focus of this paper. 
 
In addition to NSAID treatments, diets with elevated concentrations of omega-3 
fatty acids (protected in part from ruminal biohydrogenation) can be used to mildly 
decrease inflammatory status of postpartum cows. However, interpretation of most such 
studies is complicated by differences in not only inflammation but also in supply of multiple 
fatty acids that serve as precursors for prostaglandins and other reproductive hormones. 
Indeed, a recent study demonstrated that supplementing either omega-3 or omega-6 fatty 
acids during early lactation increased peak progesterone concentrations during the estrus 
cycle (Dirandeh et al., 2013), suggesting that essential fatty acid deficiency may be a 
separate issue worth considering. 
 
CONCLUSIONS 
 
 Growing interest in postpartum immunity and inflammation has led to a large 
number of basic and applied dairy cattle studies in the past decade. We now have a 
handful of nutritional and environmental risk factors that are known to contribute to poor 
immune function, adding additional motivation to address these problems. Health and 
productivity responses to anti-inflammatory treatment have been inconsistent, despite 
fairly consistent evidence that cows with heightened inflammation in the days after calving 
produce less milk and suffer from more disease. Ongoing research will hopefully bring 
additional clarity about the benefits and potential risks of several postpartum anti-
inflammatory strategies. In the meantime, reducing subclinical and clinical infection 
incidence can provide the additional benefit of decreasing pro-inflammatory signaling, 
improving expected production and health outcomes across the lactation. 
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